Filtry
Immunophenotypic profile and clinical characteristics of primary and secondary plasma cell leukemia
Background: Plasma cell leukemia (PCL) is a rare and very aggressive plasma cell disorder characterized by the presence of circulating plasma cells (cPC) in peripheral blood (PB). Dismal ...
Hematology
- 2021 •
- O •
- Odkaz
Rok uplatnění
O - Ostatní výsledky
Výsledek na webu
Plasma cell leukemia: from biology to treatment
Plasma cell leukemia (PCL) is a very aggressive and rare form of malignant monoclonal gammopathy characterized by the presence of plasmocytes in peripheral blood. It is classified as primary PCL occuring de novo', or as
FD - Onkologie a hematologie
- 2015 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Diagnostics of plasma cell leukemia
Plasma cell leukemia is a rare disease defined by the presence of circulating malignant plasma cells in the peripheral blood. Three patients were diagnosed with plasma cell leukemia<...
FD - Onkologie a hematologie
- 2008 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
To the Editor: Plasma cell leukemia (PCL) is the most aggressive form of plasma cell dyscrasia. It is characterized by the presence of more than 20% and/or more than 2 × 109 /L of circulating plasma
Hematology
- 2019 •
- Jimp •
- Odkaz
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Establishment and characterization of a new unique cell line from a patient with plasma cell leukemia.
Permanent hematopoietic cell line -HKT-62 was derived from the peripheral blood of a patient with a rare disease plasma cell leukemia. Immunological and morphological characterization of the cell line is p...
FD - Onkologie a hematologie
- 2004 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Characterization of a new human plasma cell leukemia cell line UHKT-944
A new interleukin-6 (IL-6)-dependent plasma cell leukemia cell line UHKT-944 was established from bone marrow cells derived from a 55-yr-old man with plasma cell leukemia. The
FD - Onkologie a hematologie
- 2015 •
- Jx •
- Odkaz
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring at diagnosis or as sec...
FD - Onkologie a hematologie
- 2013 •
- Jx •
- Odkaz
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
This multicenter retrospective study included 101 patients (median age 62 years) with secondary plasma cell leukemia (sPCL). The median time from initial multiple myeloma diagnosis to sPCL was 31 months. Fifty-five...
Oncology
- 2019 •
- Jimp •
- Odkaz
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Establishment and characterization of a new myeloma and plasma cell leukemia cell lines.
Two new permanent hematopoietic cell lines were established from a patient with myeloma and a patient with plasma cell leukemia. Morphological and immunological characterization of the lines is presented....
FD - Onkologie a hematologie
- 2004 •
- D
Rok uplatnění
D - Stať ve sborníku
Plasma cell leukemia – the forgotten disease
Background: Plasma cell leukemia (PCL) is a rare disease and possibly the most with an emphasis on diagnostics, treatment, and circulating plasma cells features. Conclusion that occurs without a previously...
Oncology
- 2019 •
- JSC •
- Odkaz
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
- 1 - 10 z 95 368